Really pleasing result, and a good recovery from last quarter....

Really pleasing result, and a good recovery from last quarter. Management continue to have tight control on costs.

Record income per US ECP ($986), but number of US ECP accounts still not demonstrably increasing over levels seen for the last 2 years - I just don't get that, but given up trying to understand it.

No information on international sales, but we should get a bit more information in the annual report if past reports are anything to go by.

Stealth, the convertible notes details are I think:

• June 30 2024 maturity - $1.2M to be paid if not converted before then
• Conversion price of 60c

Bought a few more over the last week, and wonder if the low 20s are now a thing of the past - these levels will look cheap if the 1-year RCT results are anything like the real world data.